Additional funding for trial to study drug for lung immunity in elderly patients

Lung immunity in the elderly will be the subject of a controlled clinical trial after receiving clearance to go ahead from Health Canada.

Related Keywords

Canada ,Hal Gunn ,Health Canada ,Health Canada No Objection Letter ,National Research Council ,Canada Industrial Research Assistance Program ,Shirin Kalyan ,